Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase-Reference-Cited by-同舟云学术

Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase

Published:1992-01 Issue:1 Volume:45 Page:21-31
ISSN:0952-3278
Container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids
language:en
Short-container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids

Author:

Lee P.-P.H.,Ip M.M.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry

Reference45 articles.

1. The concentration of 6-keto-PGF1α and TxB2 in plasma samples from patients with benign and malignant tumours of the breast;Nigam;Prostaglandins,1985

2. Prostaglandin F2α in benign and malignant breast tumors;Verogote;Br. J. Cancer,1985

3. Enhancement of murine mammary tumorigenesis by feeding high levels of dietary fat: a hormonal mechanism?;Welsch;J. Nat. Cancer Inst.,1983

4. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat;Carter;Cancer Res.,1983

5. Modulation of rat mammary carcinogenesis by indomethacin;McCormick;Cancer Res.,1985

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword;Lipids in Health and Disease;2021-11-27

2. Dimedone Derivative {2-[(4-Hydroxy-phenylamino)- methylene]-5,5-dimethyl-cyclohexane-1,3-dione} Plays an Important Role in Breast Cancer Treatment;Tropical Journal of Pharmaceutical Research;2015-10-14

3. Targeting breast cancer using retinoic acid trifloromethyl chalcone, a promising therapeutic strategy in the treatment of breast cancer;Bangladesh Journal of Pharmacology;2015-03-11

4. Eicosanoids and Adipokines in Breast Cancer: From Molecular Mechanisms to Clinical Considerations;Antioxidants & Redox Signaling;2013-01-20

5. Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial;The Journal of Steroid Biochemistry and Molecular Biology;2011-05